Louise Turner

Louise Turner

Auto-generated profile, based on publicly available information

Louise Turner

Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, University of Copenhagen

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2004 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ASAli salanti
Ali salanti
MDMadeleine Dahlbäck
Madeleine Dahlbäck
LTLouise Turner
Louise Turner
Morten NielsenMorten Nielsen
Morten Nielsen
LBLea Barfod
Lea Barfod
TTThor Grundtvig Theander
Thor Grundtvig Theander
In Plasmodium falciparum–endemic areas, pregnancy-associated malaria (PAM) is an important health problem. The condition is precipitated by accumulation of parasite-infected erythrocytes (IEs) in the placenta, and this process is mediated by parasite-encoded variant surface antigens (VSA) binding to chondroitin sulfate A (CSA). Parasites causing PAM express unique VSA types, VSAPAM, which can be serologically classified as sex specific and parity dependent. It is sex specific because men from malaria-endemic areas do not develop VSAPAM antibodies; it is parity dependent because women acquire anti-VSAPAM immunoglobulin (Ig) G as a function of parity. Previously, it was shown that transcription of var2csa is up-regulated in placental parasites and parasites selected for CSA binding. Here, we show the following: (a) that VAR2CSA is expressed on the surface of CSA-selected IEs; (b) that VAR2CSA is recognized by endemic plasma in a sex-specific and parity-dependent manner; (c) that high anti-VAR2CSA IgG levels can be found in pregnant women from both West and East Africa; and (d) that women with high plasma levels of anti-VAR2CSA IgG give birth to markedly heavier babies and have a much lower risk of delivering low birth weight children than women with low levels.

5 June 2013 in Nature
Verified
Journal Article
Open access
PDF file
LTLouise Turner
Louise Turner
TLThomas Lavstsen
Thomas Lavstsen
SBSanne Schou Berger
Sanne Schou Berger
CWChristian W. Wang
Christian W. Wang
JPJens E. V. Petersen
Jens E. V. Petersen
TTThor Grundtvig Theander
Thor Grundtvig Theander
Endothelial protein C receptor is shown to be the receptor for Plasmodium falciparum erythrocyte membrane protein 1 variants associated with severe malaria. Severe childhood malaria, still causing about a million deaths every year, is triggered by the binding of red blood cells infected with the parasite Plasmodium falciparum to the walls of the host's blood vessels. P. falciparum erythrocyte membrane protein 1 (PfEMP1) containing domain cassettes 8 and 13 is known to be associated with severe malaria, and here Thomas Lavstsen and colleagues identify the receptor for PfEMP1 as endothelial protein C receptor (EPCR), a protein involved in regulating blood coagulation and the inflammatory response. This work could help to explain why some episodes of malaria are life-threatening and involve severe inflammation and suggests a target for future antimalarials. Sequestration of Plasmodium falciparum-infected erythrocytes in host blood vessels is a key triggering event in the pathogenesis of severe childhood malaria, which is responsible for about one million deaths every year1. Sequestration is mediated by specific interactions between members of the P. falciparum erythrocyte membrane protein 1 (PfEMP1) family and receptors on the endothelial lining2. Severe childhood malaria is associated with expression of specific PfEMP1 subtypes containing domain cassettes (DCs) 8 and 13 (ref. 3), but the endothelial receptor for parasites expressing these proteins was unknown4,5. Here we identify endothelial protein C receptor (EPCR), which mediates the cytoprotective effects of activated protein C6, as the endothelial receptor for DC8 and DC13 PfEMP1. We show that EPCR binding is mediated through the amino-terminal cysteine-rich interdomain region (CIDRα1) of DC8 and group A PfEMP1 subfamilies, and that CIDRα1 interferes with protein C binding to EPCR. This PfEMP1 adhesive property links P. falciparum cytoadhesion to a host receptor involved in anticoagulation and endothelial cytoprotective pathways, and has implications for understanding malaria pathology and the development of new malaria interventions.

22 May 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
TLThomas Lavstsen
Thomas Lavstsen
LTLouise Turner
Louise Turner
FSFredy Saguti
Fredy Saguti
PMPamela Magistrado
Pamela Magistrado
TRThomas S. Rask
Thomas S. Rask
TTThor Grundtvig Theander
Thor Grundtvig Theander
The clinical outcome of Plasmodium falciparum infections ranges from asymptomatic parasitemia to severe malaria syndromes associated with high mortality. The virulence of P. falciparum infections is associated with the type of P. falciparum erythrocyte membrane protein 1 (PfEMP1) expressed on the surface of infected erythrocytes to anchor these to the vascular lining. Although var2csa , the var gene encoding the PfEMP1 associated with placental malaria, was discovered in 2003, the identification of the var /PfEMP1 variants associated with severe malaria in children has remained elusive. To identify var /PfEMP1 variants associated with severe disease outcome, we compared var transcript levels in parasites from 88 children with severe malaria and 40 children admitted to the hospital with uncomplicated malaria. Transcript analysis was performed by RT-quantitative PCR using a set of 42 primer pairs amplifying var subtype-specific loci covering most var /PfEMP1 subtypes. In addition, we characterized the near-full-length sequence of the most prominently expressed var genes in three patients diagnosed with severe anemia and/or cerebral malaria. The combined analysis showed that severe malaria syndromes, including severe anemia and cerebral malaria, are associated with high transcript levels of PfEMP1 domain cassette 8-encoding var genes. Transcript levels of group A var genes, including genes encoding domain cassette 13, were also significantly higher in patients with severe syndromes compared with those with uncomplicated malaria. This study specifies the var /PfEMP1 types expressed in severe malaria in children, and thereby provides unique targets for future efforts to prevent and treat severe malaria infections.

3 July 2013 in Nature
Verified
Journal Article
Open access
PDF file
LJLubin Jiang
Lubin Jiang
JMJianbing Mu
Jianbing Mu
QZQingfeng Zhang
Qingfeng Zhang
TNTing Ni
Ting Ni
PSPrakash Srinivasan
Prakash Srinivasan
LMLouis H Miller
Louis H Miller
The malaria parasite Plasmodium falciparum escapes immune detection by expressing one of 60 antigenically distinct var genes at any one time during the course of infection: here it is shown that the P. falciparum protein PfSETvs has a key role in var gene silencing through the trimethylation of histone H3K36. When the malaria parasite Plasmodium falciparum infects red blood cells, it escapes immune detection by expressing just one of 60 antigenically distinct var genes at a time, then switching to express a new gene during the course of infection. Here, Louis Miller and colleagues show that the histone H3 modification lysine 36 trimethylation (H3K36me3) is present at the transcription start site and along the gene body of silenced var genes. Knockout of the P. falciparum variant-silencing SET gene (PfSETvs) results in concurrent transcription of all 60 var genes, each one coding for a different version of the PfEMP1 membrane protein. PfSETvs therefore has a key role in var gene silencing. In addition, the PfSETvs knockout parasite generated in this work has potential as an antimalarial vaccine owing to its ability to express all PfEMP1 proteins, which should generate a broad repertoire of antibodies to protect against malaria. The variant antigen Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), which is expressed on the surface of P. falciparum-infected red blood cells, is a critical virulence factor for malaria1. Each parasite has 60 antigenically distinct var genes that each code for a different PfEMP1 protein. During infection the clonal parasite population expresses only one gene at a time before switching to the expression of a new variant antigen as an immune-evasion mechanism to avoid the host antibody response2,3. The mechanism by which 59 of the 60 var genes are silenced remains largely unknown4,5,6,7. Here we show that knocking out the P. falciparum variant-silencing SET gene (here termed PfSETvs), which encodes an orthologue of Drosophila melanogaster ASH1 and controls histone H3 lysine 36 trimethylation (H3K36me3) on var genes, results in the transcription of virtually all var genes in the single parasite nuclei and their expression as proteins on the surface of individual infected red blood cells. PfSETvs-dependent H3K36me3 is present along the entire gene body, including the transcription start site, to silence var genes. With low occupancy of PfSETvs at both the transcription start site of var genes and the intronic promoter, expression of var genes coincides with transcription of their corresponding antisense long noncoding RNA. These results uncover a previously unknown role of PfSETvs-dependent H3K36me3 in silencing var genes in P. falciparum that might provide a general mechanism by which orthologues of PfSETvs repress gene expression in other eukaryotes. PfSETvs knockout parasites expressing all PfEMP1 proteins may also be applied to the development of a malaria vaccine.

22 May 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ACAntoine Claessens
Antoine Claessens
YAYvonne Adams
Yvonne Adams
AGAshfaq Ghumra
Ashfaq Ghumra
GLGabriella Lindergard
Gabriella Lindergard
CBCaitlin C. Buchan
Caitlin C. Buchan
JRJ. Alexandra Rowe
J. Alexandra Rowe
Cerebral malaria is the most deadly manifestation of infection with Plasmodium falciparum . The pathology of cerebral malaria is characterized by the accumulation of infected erythrocytes (IEs) in the microvasculature of the brain caused by parasite adhesins on the surface of IEs binding to human receptors on microvascular endothelial cells. The parasite and host molecules involved in this interaction are unknown. We selected three P. falciparum strains (HB3, 3D7, and IT/FCR3) for binding to a human brain endothelial cell line (HBEC-5i). The whole transcriptome of isogenic pairs of selected and unselected parasites was analyzed using a variant surface antigen-supplemented microarray chip. After selection, the most highly and consistently up-regulated genes were a subset of group A-like var genes ( HB3var3 , 3D7_PFD0020c , ITvar7 , and ITvar19 ) that showed 11- to >100-fold increased transcription levels. These var genes encode P. falciparum erythrocyte membrane protein (PfEMP)1 variants with distinct N-terminal domain types (domain cassette 8 or domain cassette 13). Antibodies to HB3var3 and PFD0020c recognized the surface of live IEs and blocked binding to HBEC-5i, thereby confirming the adhesive function of these variants. The clinical in vivo relevance of the HBEC-selected parasites was supported by significantly higher surface recognition of HBEC-selected parasites compared with unselected parasites by antibodies from young African children suffering cerebral malaria (Mann–Whitney test, P = 0.029) but not by antibodies from controls with uncomplicated malaria (Mann–Whitney test, P = 0.58). This work describes a binding phenotype for virulence-associated group A P. falciparum erythrocyte membrane protein 1 variants and identifies targets for interventions to treat or prevent cerebral malaria.

26 September 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
FHFu-Lien Hsieh
Fu-Lien Hsieh
LTLouise Turner
Louise Turner
JBJani Reddy Bolla
Jani Reddy Bolla
CRCarol V. Robinson
Carol V. Robinson
TLThomas Lavstsen
Thomas Lavstsen
MHMatthew K. Higgins
Matthew K. Higgins
CD36 is a scavenger receptor involved in fatty acid metabolism, innate immunity and angiogenesis. It interacts with lipoprotein particles and facilitates uptake of long chain fatty acids. It is also the most common target of the PfEMP1 proteins of the malaria parasite, Plasmodium falciparum, tethering parasite-infected erythrocytes to endothelial receptors. This prevents their destruction by splenic clearance and allows increased parasitaemia. Here we describe the structure of CD36 in complex with long chain fatty acids and a CD36-binding PfEMP1 protein domain. A conserved hydrophobic pocket allows the hugely diverse PfEMP1 protein family to bind to a conserved phenylalanine residue at the membrane distal tip of CD36. This phenylalanine is also required for CD36 to interact with lipoprotein particles. By targeting a site on CD36 that is required for its physiological function, PfEMP1 proteins maintain the ability to tether to the endothelium and avoid splenic clearance.